secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASP Isotopes Inc. (ASPI)
CIK:        0001921865
Form:       8-K
Filed at:   2026-08-04T12:06:05+00:00
Accession:  0001193125-26-331596
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ASP Isotopes updates on PET Labs, helium, Silicon-28; Noble Africa merger with ENDRA on track
--------------------------------------------------------------------------------

- PET Labs 1H 2026 organic revenue growth >50% YoY; FY2026 revenue forecast ~$14M (up from $6M in 2025).
- Helium production at Renergen expected to commence before Sept 30, 2026; Phase 1 annualized revenue ~$27M.
- Noble Africa reverse merger with ENDRA (NDRA) expected to close in H2 2026; ASPI to own ~89% of combined company.
- Silicon-28 enrichment facility operating 48 stages; first commercial shipments of 99% enriched product expected in H2 2026.
- QLE convertible notes exchange: ~50% exchanged for ASPI common stock; remaining QLE notes ~$79.1M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1921865/000119312526331596/0001193125-26-331596-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1921865/000119312526331596/aspi-20260804.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-331596

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer